LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 100

Search options

  1. Article ; Online: IBD in the time of corona - vigilance for immune-mediated diseases.

    Moschen, Alexander R

    Nature reviews. Gastroenterology & hepatology

    2020  Volume 17, Issue 9, Page(s) 529–530

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Humans ; Immunity, Mucosal ; Inflammatory Bowel Diseases/complications ; Inflammatory Bowel Diseases/immunology ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/immunology ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-06-18
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2493722-8
    ISSN 1759-5053 ; 1759-5045
    ISSN (online) 1759-5053
    ISSN 1759-5045
    DOI 10.1038/s41575-020-0333-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Lactobacillus reuteri-an old acquaintance takes on a new task in colorectal tumor surveillance.

    Watschinger, Christina / Moschen, Alexander R

    Cancer cell

    2022  Volume 40, Issue 2, Page(s) 125–127

    Abstract: In this issue of Cancer Cell, Bell et al. identify the commensal bacterium Lactobacillus reuteri and its major metabolite reuterin as an important gatekeeper and promising target in colorectal cancerogenesis. They decipher a metabolic interplay in which ... ...

    Abstract In this issue of Cancer Cell, Bell et al. identify the commensal bacterium Lactobacillus reuteri and its major metabolite reuterin as an important gatekeeper and promising target in colorectal cancerogenesis. They decipher a metabolic interplay in which L. reuteri is suppressed by metabolites from dysplastic intestinal epithelial cells which in turn are highly sensitive to the oxidative effects of the electrophile reuterin.
    MeSH term(s) Bacteria ; Colorectal Neoplasms ; Friends ; Humans ; Lactobacillus reuteri/metabolism
    Language English
    Publishing date 2022-02-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2078448-X
    ISSN 1878-3686 ; 1535-6108
    ISSN (online) 1878-3686
    ISSN 1535-6108
    DOI 10.1016/j.ccell.2022.01.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade.

    Tilg, Herbert / Adolph, Timon E / Moschen, Alexander R

    Hepatology (Baltimore, Md.)

    2021  Volume 73, Issue 2, Page(s) 833–842

    MeSH term(s) Adipokines/metabolism ; Adipose Tissue/immunology ; Adipose Tissue/metabolism ; Animals ; Disease Models, Animal ; Gastrointestinal Microbiome/immunology ; Humans ; Lipid Metabolism/genetics ; Lipid Metabolism/immunology ; Liver/immunology ; Liver/pathology ; Non-alcoholic Fatty Liver Disease/etiology ; Non-alcoholic Fatty Liver Disease/pathology ; Signal Transduction/immunology
    Chemical Substances Adipokines
    Language English
    Publishing date 2021-02-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1002/hep.31518
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients.

    Moschen, Alexander R / Sammy, Yossi / Marjenberg, Zoe / Heptinstall, Amy B / Pooley, Nick / Marczewska, Agnieszka M

    Current oncology reports

    2022  Volume 24, Issue 7, Page(s) 861–874

    Abstract: Purpose of review: This review aims to summarize and discuss the diverse causes of two major gastrointestinal dysfunction symptoms, diarrhea and constipation, in cancer patients. We also discuss short- and long-term clinical, economic, and humanistic ... ...

    Abstract Purpose of review: This review aims to summarize and discuss the diverse causes of two major gastrointestinal dysfunction symptoms, diarrhea and constipation, in cancer patients. We also discuss short- and long-term clinical, economic, and humanistic consequences, including the impact on cancer treatment regimens and patient quality of life, highlighting the limitations of the literature.
    Recent findings: Diarrhea and constipation as a result of cancer and its treatment can risk the success of anti-cancer therapies by requiring treatment delay or withdrawal, and imposes a substantial humanistic burden in patients with cancer. Despite its importance and frequency, gastrointestinal side effects may be overlooked due to the focus on cancer treatment, and the impact on patients may be underestimated. Additionally, the burden reported may not fully reflect current cancer management, particularly the true impact of economic consequences. A full understanding of the burden of diarrhea and constipation in patients with cancer is required, including broad evaluation of clinical considerations, the patient experience, and an updated assessment of economic burden. This would improve caregivers' appreciation of the impact of gastrointestinal dysfunction and aid the prioritization of future research efforts.
    MeSH term(s) Caregivers ; Constipation/complications ; Constipation/etiology ; Diarrhea/epidemiology ; Diarrhea/etiology ; Gastrointestinal Tract ; Humans ; Neoplasms/complications ; Quality of Life
    Language English
    Publishing date 2022-03-24
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2057359-5
    ISSN 1534-6269 ; 1523-3790
    ISSN (online) 1534-6269
    ISSN 1523-3790
    DOI 10.1007/s11912-022-01267-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Immunsuppressiva bei Morbus Crohn

    Moschen, Alexander R.

    Wiener medizinische Wochenschrift : Skriptum : Kongressjournal

    2015  Volume 12, Issue 13, Page(s) 4

    Language German
    Document type Article
    ZDB-ID 2142526-7
    ISSN 1613-3803 ; 0043-5341
    Database Current Contents Medicine

    More links

    Kategorien

  6. Article: Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic Targets.

    Weidinger, Carl / Krug, Susanne M / Voskens, Caroline / Moschen, Alexander R / Atreya, Imke

    Frontiers in medicine

    2021  Volume 8, Page(s) 813153

    Language English
    Publishing date 2021-12-09
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2021.813153
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting.

    Moschen, Alexander R / Tilg, Herbert / Raine, Tim

    Nature reviews. Gastroenterology & hepatology

    2018  Volume 16, Issue 3, Page(s) 185–196

    Abstract: IL-12 and IL-23 are closely related cytokines with important roles in the regulation of tissue inflammation. Converging evidence from studies in mice, human observational studies and population genetics supports the importance of these cytokines in the ... ...

    Abstract IL-12 and IL-23 are closely related cytokines with important roles in the regulation of tissue inflammation. Converging evidence from studies in mice, human observational studies and population genetics supports the importance of these cytokines in the regulation of mucosal inflammation in the gut in particular. Ustekinumab, a therapeutic antibody targeting both cytokines is now widely licensed for the treatment of Crohn's disease, including in Europe, the USA, Canada and Japan, whilst agents targeting IL-23 specifically are in late-phase clinical trials. We review the emerging understanding of the biology of IL-12 and IL-23, as well as that of their major downstream cytokines, including IL-17. In particular, we discuss how their biology has influenced the development of clinical trials and therapeutic strategies in IBD, as well as how findings from clinical trials, at times surprising, have in turn refocused our understanding of the underlying biology.
    MeSH term(s) Animals ; Humans ; Inflammatory Bowel Diseases/etiology ; Inflammatory Bowel Diseases/immunology ; Inflammatory Bowel Diseases/therapy ; Interleukin-12/physiology ; Interleukin-17/physiology ; Interleukin-23/physiology
    Chemical Substances Interleukin-17 ; Interleukin-23 ; Interleukin-12 (187348-17-0)
    Language English
    Publishing date 2018-11-23
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2493722-8
    ISSN 1759-5053 ; 1759-5045
    ISSN (online) 1759-5053
    ISSN 1759-5045
    DOI 10.1038/s41575-018-0084-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines.

    Karbiener, Michael / Farcet, Maria R / Zollner, Andreas / Masuda, Taisei / Mori, Mitsuhiro / Moschen, Alexander R / Kreil, Thomas R

    NPJ vaccines

    2022  Volume 7, Issue 1, Page(s) 22

    Abstract: SARS-CoV-2 neutralizing antibodies have been suggested to reflect the efficacy of COVID-19 vaccines. This study reports the direct comparison of the SARS-CoV-2 neutralizing antibody response elicited by a protein- (NVX-CoV2373), an mRNA- (Comirnaty), and ...

    Abstract SARS-CoV-2 neutralizing antibodies have been suggested to reflect the efficacy of COVID-19 vaccines. This study reports the direct comparison of the SARS-CoV-2 neutralizing antibody response elicited by a protein- (NVX-CoV2373), an mRNA- (Comirnaty), and a vector-based (Vaxzevria) COVID-19 vaccine, calibrated against the WHO international SARS-CoV-2 antibody standard, and further supports the use of neutralizing antibody levels as a correlate of protection.
    Language English
    Publishing date 2022-02-18
    Publishing country England
    Document type Journal Article
    ISSN 2059-0105
    ISSN (online) 2059-0105
    DOI 10.1038/s41541-022-00455-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Food, immunity, and the microbiome.

    Tilg, Herbert / Moschen, Alexander R

    Gastroenterology

    2015  Volume 148, Issue 6, Page(s) 1107–1119

    Abstract: There is increasing evidence that ingested diet-borne components are involved in the pathogenesis of disorders such as inflammatory bowel diseases, atherosclerosis, and type 2 diabetes. Nutrients can have short- and long-term effects in shaping the ... ...

    Abstract There is increasing evidence that ingested diet-borne components are involved in the pathogenesis of disorders such as inflammatory bowel diseases, atherosclerosis, and type 2 diabetes. Nutrients can have short- and long-term effects in shaping the composition of the microbiota. Western diets (enriched in fat, phosphatidylcholine, and L-carnitine) promote inflammation and atherosclerosis through specific fatty acids and degradation products such as trimethylamine N-oxide. Other dietary factors such as carbazoles or tryptophan-enriched proteins have anti-inflammatory properties-partly via activation of aryl hydrocarbon receptors. The microbiota and its metabolic machinery produce a myriad of metabolites that serve as important messengers between the diet, microbiota, and host. Short-chain fatty acids affect immune responses and epithelial integrity via G-protein-coupled receptors and epigenetic mechanisms. By increasing our understanding of interactions between diet, immunity, and the microbiota, we might develop food-based approaches to prevent or treat many diseases. There now is scientific evidence to support the adage "we are what we eat," and this process begins in early life.
    MeSH term(s) Animals ; Diet/adverse effects ; Energy Metabolism ; Gastrointestinal Tract/immunology ; Gastrointestinal Tract/metabolism ; Gastrointestinal Tract/microbiology ; Gastrointestinal Tract/physiopathology ; Host-Pathogen Interactions ; Humans ; Immunity, Mucosal ; Inflammation/diet therapy ; Inflammation/immunology ; Inflammation/microbiology ; Inflammation/physiopathology ; Malnutrition/diet therapy ; Malnutrition/immunology ; Malnutrition/microbiology ; Malnutrition/physiopathology ; Microbiota ; Nutritional Status ; Risk Factors
    Language English
    Publishing date 2015-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80112-4
    ISSN 1528-0012 ; 0016-5085
    ISSN (online) 1528-0012
    ISSN 0016-5085
    DOI 10.1053/j.gastro.2014.12.036
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top